What is the address of ICONE-RX?

The registered office of ICONE-RX is located at Chaussée de Tubize(W-B) 103, 1440 Braine-le-Château.

Is ICONE-RX still active?

Yes. According to the CBE (2 November 2026) ICONE-RX is active, legal situation “Normale toestand”, started on 29 June 2023.

Is ICONE-RX registered on Peppol?

No, ICONE-RX is currently not registered on the Peppol network.

What is the enterprise number of ICONE-RX?

The enterprise number of ICONE-RX is BE0803331333.

When was ICONE-RX founded?

ICONE-RX was founded on 29 June 2023.

The shares are held by DECEUNINCK-PARENT (33.3%).

Is ICONE-RX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 June 2023; 3 annual accounts filed, latest fiscal year 2026.

How much profit did ICONE-RX make in 2026?

ICONE-RX recorded a loss after taxes of € 19,623 in financial year 2026.

What is the revenue of ICONE-RX?

As a small company, ICONE-RX is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € -16,211.

ICONE-RX (Private Limited) - Braine-le-Château

Dossier ICONE-RX, printed on 2 November 2026 from databakkes.be/en/0803331333/icone-rx. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 1 of the last 3 fiscal years.
Two loss years in a row NBB

Negative result in 2025 and 2026.
Tight liquidity NBB

Cash and receivables cover 6 % of short-term debt in 2026; threshold 65 %.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2026

ICONE-RX from Braine-le-Château, company number BE0803331333, closed financial year 2026 with a result of € -19,623 after tax. For that financial year ICONE-RX recorded a gross margin of € -16,211 and equity of € -15,287. Compared with financial year 2025, the result moved from € -8,316 to € -19,623. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 29, 2026.

What it is worth Caution

€ -15,287

▼ € 19,623 vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -19,623

▼ 136 % more loss than in 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 21,716

▼ 43% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -30,287.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,254

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2024	2025	2026	Change 2025 → 2026
Gross margin	€ -194 Gross margin 2024: € -194 First fiscal year in the series	€ -1,920 Gross margin 2025: € -1,920 ▼ € 1,726 vs 2024 (€ -194) Unfavourable step	€ -16,211 Gross margin 2026: € -16,211 ▼ € 14,291 vs 2025 (€ -1,920) Unfavourable step	▼ € 14,291
Profit after taxes	€ -2,348 Profit after taxes 2024: € -2,348 First fiscal year in the series	€ -8,316 Profit after taxes 2025: € -8,316 ▼ € 5,967 vs 2024 (€ -2,348) Unfavourable step	€ -19,623 Profit after taxes 2026: € -19,623 ▼ € 11,307 vs 2025 (€ -8,316) Unfavourable step	▼ € 11,307
Equity	€ 12,652 Equity 2024: € 12,652 First fiscal year in the series	€ 4,336 Equity 2025: € 4,336 ▼ 66% vs 2024 (€ 12,652) Unfavourable step	€ -15,287 Equity 2026: € -15,287 ▼ € 19,623 vs 2025 (€ 4,336) Unfavourable step	▼ € 19,623
Total debts	€ 379,284 Total debts 2024: € 379,284 First fiscal year in the series	€ 377,375 Total debts 2025: € 377,375 ▼ 1% vs 2024 (€ 379,284) Favourable step	€ 381,757 Total debts 2026: € 381,757 ▲ 1% vs 2025 (€ 377,375) Unfavourable step	▲ 1%
Cash	€ 55,398 Cash 2024: € 55,398 First fiscal year in the series	€ 37,969 Cash 2025: € 37,969 ▼ 31% vs 2024 (€ 55,398) Unfavourable step	€ 21,716 Cash 2026: € 21,716 ▼ 43% vs 2025 (€ 37,969) Unfavourable step	▼ 43%
Land & buildings	€ 306,807 Land & buildings 2024: € 306,807 First fiscal year in the series	€ 306,807 Land & buildings 2025: € 306,807 Unchanged (€ 306,807) Unchanged	€ 306,807 Land & buildings 2026: € 306,807 Unchanged (€ 306,807) Unchanged
Retained profit	€ -2,348 Retained profit 2024: € -2,348 First fiscal year in the series	€ -10,664 Retained profit 2025: € -10,664 ▼ € 8,316 vs 2024 (€ -2,348) Unfavourable step	€ -30,287 Retained profit 2026: € -30,287 ▼ € 19,623 vs 2025 (€ -10,664) Unfavourable step	▼ € 19,623
Balance sheet total	€ 391,936 Balance sheet total 2024: € 391,936 First fiscal year in the series	€ 381,711 Balance sheet total 2025: € 381,711 ▼ 3% vs 2024 (€ 391,936) Unchanged	€ 366,470 Balance sheet total 2026: € 366,470 ▼ 4% vs 2025 (€ 381,711) Unchanged	▼ 4%

Key figures of ICONE-RX, fiscal years 2024 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to ICONE-RX?

What happened at ICONE-RX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 29, 2026 New annual accounts for financial year 2026: loss of € 19,623. Source: NBB ↗
Jun 29, 2023 New establishment in Braine-le-Château. KBO
Jun 29, 2023 Start of the company according to the CBE. KBO

In short

From € 2,348 loss in 2024 to € 19,623 loss in 2026.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée de Tubize(W-B) 103

1440 Braine-le-Château

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0803.331.333
VAT number: BE 0803.331.333
Registered office: Chaussée de Tubize(W-B) 103, 1440 Braine-le-Château
Names & denominations: ICONE-RX
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 June 2023
Peppol: Not registered
Contact: [email protected] +32498194047

View on CBE Public ↗ Annual accounts (NBB) ↗

ICONE-RX